Literature DB >> 23539521

Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.

Bin Xu1, Wei-Xing Ding, Da-Yong Jin, Dan-Song Wang, Wen-Hui Lou.   

Abstract

AIM: To identify a practical approach for preoperative decision-making in patients with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.
METHODS: Between March 1999 and November 2006, the clinical characteristics, pathological data and computed tomography/magnetic resonance imaging (CT/MRI) of 54 IPMNs cases were retrieved and analyzed. The relationships between the above data and decision-making for pancreatic resection were analyzed using SPSS 13.0 software. Univariate analysis of risk factors for malignant or invasive IPMNs was performed with regard to the following variables: carcinoembryonic antigen, carbohydrate antigen 19-9 (CA19-9) and the characteristics from CT/MRI images. Receiver operating characteristic (ROC) curve analysis for pancreatic resection was performed using significant factors from the univariate analysis.
RESULTS: CT/MRI images, including main and mixed duct IPMNs, tumor size > 30 mm or a solid component appearance in the lesion, and preoperative serum CA19-9 > 37 U/mL had good predictive value for determining pancreatic resection (P < 0.05), but with limitations. Combining the above factors (CT/MRI images and CA19-9) improved the accuracy and sensitivity for determining pancreatic resection in IPMNs. Using ROC analysis, the area under the curve reached 0.893 (P < 0.01, 95%CI: 0.763-1.023), with a sensitivity, specificity, positive predictive value and negative predictive value of 95.2%, 83.3%, 95.2% and 83.3%, respectively.
CONCLUSION: Combining preoperative CT/MRI images and CA19-9 level may provide useful information for surgical decision-making in IPMNs.

Entities:  

Keywords:  Carbohydrate antigen 19-9; Computed tomography/magnetic resonance imaging; Intraductal papillary mucinous neoplasms; Predictor; Surgical decision-making

Mesh:

Substances:

Year:  2013        PMID: 23539521      PMCID: PMC3602505          DOI: 10.3748/wjg.v19.i9.1451

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct.

Authors:  B Terris; P Ponsot; F Paye; P Hammel; A Sauvanet; G Molas; P Bernades; J Belghiti; P Ruszniewski; J F Fléjou
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.

Authors:  Dae Wook Hwang; Jin-Young Jang; Seung Eun Lee; Chang-Sup Lim; Kuhn Uk Lee; Sun-Whe Kim
Journal:  Langenbecks Arch Surg       Date:  2010-07-18       Impact factor: 3.445

3.  Impact of endoscopic ultrasound-guided fine needle biopsy for diagnosis of pancreatic masses.

Authors:  Julio Iglesias-Garcia; Enrique Dominguez-Munoz; Antonio Lozano-Leon; Ihab Abdulkader; Jose Larino-Noia; Jose Antunez; Jeronimo Forteza
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 4.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

5.  Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.

Authors:  Dushyant V Sahani; Rajagopal Kadavigere; Michael Blake; Carlos Fernandez-Del Castillo; Gregory Y Lauwers; Peter F Hahn
Journal:  Radiology       Date:  2006-02       Impact factor: 11.105

Review 6.  Intraductal papillary mucinous neoplasms of the pancreas.

Authors:  W B Al-Refaie; E A Choi; J F Tseng; E P Tamm; J H Lee; J E Lee; D B Evans; P W T Pisters
Journal:  Med Princ Pract       Date:  2006       Impact factor: 1.927

7.  Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?

Authors:  Jin-Young Jang; Sun-Whe Kim; Young Joon Ahn; Yoo-Seok Yoon; Min Gew Choi; Kuhn Uk Lee; Joon Koo Han; Woo Ho Kim; Young Joo Lee; Song Chul Kim; Duck Jong Han; Yong Il Kim; Seong Ho Choi; Baik Hwan Cho; Hee Chul Yu; Dong Sup Yoon; Woo Jung Lee; Kyung Bum Lee; Young Chul Kim; Kwang Soo Lee; Myung-Wook Kim; Hong Jin Kim; Hyun Jong Kim; Yong-Hyun Park
Journal:  Ann Surg Oncol       Date:  2005-02-04       Impact factor: 5.344

8.  Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis.

Authors:  David A Tessler; Andrew Catanzaro; Vic Velanovich; Suzanne Havstad; Sachin Goel
Journal:  Am J Surg       Date:  2006-02       Impact factor: 2.565

9.  Technology insight: applications of MRI for the evaluation of benign disease of the pancreas.

Authors:  Timothy P Kinney; Gopal Punjabi; Martin Freeman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-03

10.  Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Shin-E Wang; Yi-Ming Shyr; Tien-Hua Chen; Cheng-Hsi Su; Tsann-Long Hwang; Kuo-Shyang Jeng; Jui-Hao Chen; Chew-Wun Wu; Wing-Yiu Lui
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

View more
  2 in total

Review 1.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 2.  Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas.

Authors:  M Heckler; L Brieger; U Heger; T Pausch; C Tjaden; J Kaiser; M Tanaka; T Hackert; C W Michalski
Journal:  BJS Open       Date:  2018-02-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.